Kawasaki Disease Diagnostic Criteria Calculator

Clinical Overview

Kawasaki disease (KD) is the most common acquired heart disease in children in developed countries, primarily affecting children under 5 years of age. It is a self-limited medium-vessel vasculitis with a particular predilection for the coronary arteries. Without treatment, approximately 25% of affected children develop coronary artery aneurysms, making early recognition and timely administration of intravenous immunoglobulin (IVIG) critical.

The diagnostic criteria for Kawasaki disease are clinical — there is no definitive laboratory test. Classic (complete) KD is defined by the presence of fever lasting at least 5 days plus at least 4 of the 5 principal clinical features:

1. Bilateral bulbar conjunctival injection — non-exudative, limbus-sparing
2. Oral mucous membrane changes — erythema, cracking of lips, strawberry tongue, or diffuse oropharyngeal injection
3. Polymorphous rash — maculopapular, diffuse erythroderma, or erythema multiforme-like (never vesicular or bullous)
4. Extremity changes — erythema or edema of hands/feet acutely; periungual desquamation in the subacute phase
5. Cervical lymphadenopathy — usually unilateral, ≥1.5 cm diameter

A major diagnostic challenge is incomplete Kawasaki disease, which accounts for a substantial proportion of cases — particularly in infants under 6 months, who paradoxically carry the highest risk for coronary complications. The 2017 AHA scientific statement (updated in 2024) established a systematic algorithm for evaluating suspected incomplete KD using supplemental laboratory and echocardiographic criteria.

This calculator implements both the classic diagnostic criteria and the AHA incomplete KD algorithm, guiding clinicians through the stepwise evaluation process.

Interpretation Guide

The calculator classifies patients into one of several diagnostic categories based on the input data:

Classic Kawasaki Disease is diagnosed when fever has persisted for 5 or more days and at least 4 of the 5 principal features are present. In practice, experienced clinicians may make the diagnosis on day 4 of fever if 4 or more features are present ("Likely Classic KD"), and treatment should not be delayed. KD can also be diagnosed with fewer than 4 features if coronary artery abnormalities are detected on echocardiography.

Incomplete Kawasaki Disease evaluation is triggered when a child has 5 or more days of fever with only 2 or 3 principal features. The AHA algorithm then proceeds as follows: check CRP and ESR. If CRP is ≥3.0 mg/dL or ESR is ≥40 mm/hr, evaluate supplemental laboratory criteria — hypoalbuminemia (≤3.0 g/dL), anemia for age, elevated ALT, thrombocytosis after day 7 (platelets >450,000), leukocytosis (WBC ≥15,000), and sterile pyuria (≥10 WBC/hpf). If 3 or more supplemental criteria are met, or if echocardiography is abnormal, the diagnosis of incomplete KD is supported and treatment should proceed. If fewer than 3 supplemental criteria are met and the echo is normal, the evaluation is inconclusive — serial clinical monitoring and repeat echocardiography are recommended.

Common pitfalls in interpretation:

The features of KD need not be present simultaneously. A careful history may reveal that features appeared and resolved before the clinical evaluation. Lymphadenopathy is the least common principal feature, present in only about 50% of cases. In infants under 12 months, incomplete presentations are especially common and the threshold for evaluation should be low — prolonged unexplained fever in an infant with even one principal feature warrants inflammatory marker assessment. The calculator provides a specific warning for infants under 1 year.

A normal echocardiogram does not exclude KD. Coronary changes may develop later, and treatment should not be withheld if clinical suspicion is high. Conversely, some patients ultimately diagnosed with KD initially present with features mimicking adenoviral infection, scarlet fever, Stevens-Johnson syndrome, or systemic juvenile idiopathic arthritis.

Evidence & Validation

The diagnostic criteria for Kawasaki disease were first codified in Japan by Tomisaku Kawasaki himself in the 1960s–1970s and have been refined through decades of international consensus. The current standard is the American Heart Association scientific statement originally published in 2017 by McCrindle BW, Rowley AH, Newburger JW, et al. (Circulation. 2017;135(17):e927-e999. DOI: 10.1161/CIR.0000000000000484), with an important update in 2024 by Jone PN, Tremoulet A, Engel T, et al. (Circulation. 2024;150(23):e481-e500. DOI: 10.1161/CIR.0000000000001295).

The incomplete KD algorithm was developed in response to epidemiologic data showing that a significant proportion of children with confirmed KD — particularly those under 6 months — did not meet classic criteria. In a study from the Pediatric Heart Network, approximately 36% of children with KD presented with incomplete features. These children had comparable rates of coronary artery abnormalities to those with classic presentations, underscoring the importance of a systematic evaluation pathway.

The supplemental laboratory criteria were selected based on their ability to distinguish KD from febrile controls. Individually, each criterion has modest sensitivity but reasonable specificity. The combination of ≥3 supplemental criteria provides a practical threshold that balances the risk of underdiagnosis (and missed coronary pathology) against overtreatment.

Key limitations: The criteria remain imperfect as a diagnostic standard. There is no gold-standard confirmatory test for KD — the diagnosis is clinical, and even the AHA algorithm is a consensus-based guideline rather than a validated predictive model with reported sensitivity and specificity values. Cultural and geographic variation in KD presentations exists, and the criteria are primarily derived from North American and Japanese cohorts. The 2024 update emphasizes that clinical judgment remains paramount, and the criteria should be used as a diagnostic aid rather than an absolute threshold.

Echocardiographic criteria for coronary involvement have also evolved. The current standard uses body surface area–adjusted Z-scores (see Centilo's Coronary Z-Score calculator) rather than absolute diameter cutoffs, which improves accuracy across the pediatric size range.

Worked Example

Clinical Scenario: A 3-year-old boy presents on day 6 of high fever (up to 39.8°C) that has been unresponsive to antipyretics. On examination, he has bilateral non-exudative conjunctival injection, cracked erythematous lips with a strawberry tongue, and a diffuse maculopapular rash on his trunk. His hands are mildly edematous. There is no cervical lymphadenopathy.

Step 1 — Count principal features:

• Conjunctival injection: present ✓
• Oral changes: present ✓
• Rash: present ✓
• Extremity changes: present ✓
• Lymphadenopathy: absent ✗

Feature count: 4 of 5

Step 2 — Apply diagnostic criteria: Fever ≥5 days (day 6) + 4 principal features = Classic Kawasaki Disease

Result: The calculator returns "CLASSIC KAWASAKI DISEASE" — criteria are met. This child should receive IVIG 2 g/kg as a single infusion plus high-dose aspirin (80–100 mg/kg/day in 4 divided doses, or 30–50 mg/kg/day per institutional protocol) within 10 days of fever onset. Baseline echocardiography should be obtained, ideally before treatment but should not delay IVIG administration. Follow-up echocardiography is recommended at 2 weeks and 6–8 weeks after treatment.

If this same child had presented with only 2 of the 5 features, the calculator would trigger the incomplete KD pathway. With a CRP of 4.5 mg/dL and supplemental findings of albumin 2.8 g/dL, WBC 18,000, and platelet count of 480,000 on day 8, the calculator would identify 3 supplemental criteria met and return "INCOMPLETE KAWASAKI DISEASE — criteria met", again warranting IVIG treatment.

Keywords: Kawasaki disease, KD, incomplete Kawasaki, diagnostic criteria, AHA guidelines, coronary artery aneurysm, IVIG, vasculitis, fever, pediatric cardiology, conjunctivitis, strawberry tongue, rash, lymphadenopathy, extremity changes, McCrindle, echocardiography

References

1. McCrindle BW, Rowley AH, Newburger JW, et al. Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association. Circulation. 2017;135(17):e927-e999. doi:10.1161/CIR.0000000000000484
2. Jone PN, Tremoulet A, Engel T, et al. Update on diagnosis and management of Kawasaki disease: a scientific statement from the American Heart Association. Circulation. 2024;150(23):e481-e500. doi:10.1161/CIR.0000000000001295